IL15 and Sepsis: However, we recently showed in a mouse model that purified NK cells are responsive to TLR agonists in the presence of IL-15/IL-18 and that they become tolerant to this ex vivo challenge following polymicrobial sepsis [55], which is in favor of a deactivation of NK cells themselves.